-
Optimizing the online experience for disabilities improves it for all customers
What if I told you there’s a huge, under-served consumer group that you can market to in such a way that it will improve all your marketing? Bet you’d be pretty interested. Good news: There is. And, if that’s not incentive enough, failing to address their needs could get you sued under a major federal…
-
3 things to know about the American Data Protection and Privacy Act
The American Data Protection and Privacy Act, if passed, would represent federal legislation pre-empting state data privacy regulation. It’s a big deal, not least because in its current version it has bipartisan support. It’s important to emphasize “current version,” because it has been through several drafts and may get extensively amended or rewritten between now…
-
Only 11% of US businesses fully comply with CCPA privacy law
Only 11% of US businesses fully meet California Consumer Privacy Act (CCPA) requirements, according to a new study. This is actually higher than the 6% fully compliant with the EU’s General Data Protection Regulation (GDPR). Read next: Federal data privacy bill could make life easier for marketers The rest of the companies are either non-compliant…
-
Federal data privacy bill could make life easier for marketers
A new data privacy bill (H.R.8152) could help marketers, even as it makes targeted advertising more difficult. The American Data Privacy and Protection Act (ADDPA) would provide a wide-reaching national privacy standard, overriding existing state privacy laws. As a result, marketers would only have to conform to one regulation instead of the 13 currently in…
-
Five human issues that can wreck a technology implementation
There’s far more than tech to martech. That may seem counterintuitive, but the longer I work in this field, the more I realize it’s true. Especially when it comes to implementations and integrations. While there’s always the risk of technical problems, people-related issues can wreak as much havoc, if not more. Let’s examine some of…